By Memorandum Order entered by The Honorable Gregory M. Sleet in Arrowpoint Capital Corp. v. Arrowpoint Asset Management, LLC, et al., Civil Action No. 10-161 (D.Del. October 11, 2016), the Court granted Plaintiff Arrowpoint Capital Corp.’s motion for partial summary judgment in its trademark infringement action against Defendants Arrowpoint Asset Management, LLC, et al

By Memorandum Order entered by The Honorable Sue L. Robinson in Adtile Technologies, Inc. v. Perion Network Ltd., et al., Civil Action No. 15-1193-SLR (D.Del., June 23, 2016), the Court denied plaintiff Adtile Technologies, Inc.’s motion for preliminary injunction after concluding that Adtile had not shown likelihood of success on the merits of the

By Memorandum Opinion and Order entered by The Honorable Sue L. Robinson in AstraZeneca AB, et al. v. Camber Pharmaceuticals, Inc., Civil Action No. 15-927-SLR (D.Del., November 19, 2015), the Court granted the AstraZeneca plaintiffs’ motion for a preliminary injunction against defendant Camber Pharmaceuticals thereby enjoining defendant from selling its generic esomeprazole product (a

Gregory B. Williams, a partner in the Wilmington, DE and Philadelphia, PA offices of Fox Rothschild, has been named to Delaware Today’s Top Lawyer List for 2015 for Civil Litigation.  Greg, an experienced litigator and trial attorney with more than 20 years of experience, has a diverse practice focused on commercial, intellectual property and other

By Memorandum Opinion entered by The Honorable Sue L. Robinson in AstraZeneca AB, et al. v. Dr. Reddy’s Laboratories, Inc., Civil Action No. 15-988-SLR (D.Del., November 6, 2015), the Court granted the AstraZeneca plaintiffs’ motion for a temporary restraining order, including ordering defendant to immediately stop the sale, delivery, transfer, or other disposition of

By Memorandum Order entered by the Honorable Sue L. Robinson in Schering-Plough Healthcare Products, Inc. v. Neutrogena Corporation, Civil Action No. 09-642-SLR (D.Del., June 8, 2011), the Court denied the motion for permanent injunction of plaintiff Schering-Plough Healthcare Products, Inc. (“Schering-Plough”) seeking to enjoin defendant Neutrogena Corporation (“Neutrogena”) from all future use of the